Application of the Lee Silverman voice treatment (LSVT®) to individuals with multiple sclerosis, ataxic dysarthria, and stroke

Leslie Will; Lorraine O. Ramig; Jennifer Spielman

Application of the Lee Silverman voice treatment (LSVT^®) to individuals with multiple sclerosis, ataxic dysarthria, and stroke

Leslie Will
, Lorraine O. Ramig
, Jennifer Spielman

Research output: Contribution to conference › Paper › peer-review

4 Scopus citations

Abstract

Reduced speech intelligibility has been observed in Parkinson's disease (PD), ataxic dysarthria, multiple sclerosis (MS) and in individuals who have suffered a cerebral vascular accident (CVA). Data support the effectiveness of the Lee Silverman Voice Treatment (LSVT) on the improvement of vocal function and speech intelligibility in PD. Today, only a small percentage of patients with chronic neurologic disease receive treatment to improve speech and voice. This paper will report improvement in case studies of individuals with MS, ataxic dysarthria and CVA and suggest that the effects of LSVT may not be restricted to the dysarthria associated with PD.

Original language	English
Pages	2497-2500
Number of pages	4
State	Published - 2002
Externally published	Yes
Event	7th International Conference on Spoken Language Processing, ICSLP 2002 - Denver, United States Duration: 16 Sep 2002 → 20 Sep 2002

Conference

Conference	7th International Conference on Spoken Language Processing, ICSLP 2002
Country/Territory	United States
City	Denver
Period	16/09/02 → 20/09/02

Cite this

@conference{1e0e5ce6796a4fe991162a72d0194b39,

title = "Application of the Lee Silverman voice treatment (LSVT{\textregistered}) to individuals with multiple sclerosis, ataxic dysarthria, and stroke",

abstract = "Reduced speech intelligibility has been observed in Parkinson's disease (PD), ataxic dysarthria, multiple sclerosis (MS) and in individuals who have suffered a cerebral vascular accident (CVA). Data support the effectiveness of the Lee Silverman Voice Treatment (LSVT) on the improvement of vocal function and speech intelligibility in PD. Today, only a small percentage of patients with chronic neurologic disease receive treatment to improve speech and voice. This paper will report improvement in case studies of individuals with MS, ataxic dysarthria and CVA and suggest that the effects of LSVT may not be restricted to the dysarthria associated with PD.",

author = "Leslie Will and Ramig, \{Lorraine O.\} and Jennifer Spielman",

year = "2002",

language = "English",

pages = "2497--2500",

note = "7th International Conference on Spoken Language Processing, ICSLP 2002 ; Conference date: 16-09-2002 Through 20-09-2002",

}

Application of the Lee Silverman voice treatment (LSVT^®) to individuals with multiple sclerosis, ataxic dysarthria, and stroke. / Will, Leslie; Ramig, Lorraine O.; Spielman, Jennifer.
2002. 2497-2500 Paper presented at 7th International Conference on Spoken Language Processing, ICSLP 2002, Denver, United States.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Application of the Lee Silverman voice treatment (LSVT®) to individuals with multiple sclerosis, ataxic dysarthria, and stroke

AU - Will, Leslie

AU - Ramig, Lorraine O.

AU - Spielman, Jennifer

PY - 2002

Y1 - 2002

N2 - Reduced speech intelligibility has been observed in Parkinson's disease (PD), ataxic dysarthria, multiple sclerosis (MS) and in individuals who have suffered a cerebral vascular accident (CVA). Data support the effectiveness of the Lee Silverman Voice Treatment (LSVT) on the improvement of vocal function and speech intelligibility in PD. Today, only a small percentage of patients with chronic neurologic disease receive treatment to improve speech and voice. This paper will report improvement in case studies of individuals with MS, ataxic dysarthria and CVA and suggest that the effects of LSVT may not be restricted to the dysarthria associated with PD.

AB - Reduced speech intelligibility has been observed in Parkinson's disease (PD), ataxic dysarthria, multiple sclerosis (MS) and in individuals who have suffered a cerebral vascular accident (CVA). Data support the effectiveness of the Lee Silverman Voice Treatment (LSVT) on the improvement of vocal function and speech intelligibility in PD. Today, only a small percentage of patients with chronic neurologic disease receive treatment to improve speech and voice. This paper will report improvement in case studies of individuals with MS, ataxic dysarthria and CVA and suggest that the effects of LSVT may not be restricted to the dysarthria associated with PD.

UR - https://www.scopus.com/pages/publications/84941160130

M3 - Paper

AN - SCOPUS:84941160130

SP - 2497

EP - 2500

T2 - 7th International Conference on Spoken Language Processing, ICSLP 2002

Y2 - 16 September 2002 through 20 September 2002

ER -

Application of the Lee Silverman voice treatment (LSVT®) to individuals with multiple sclerosis, ataxic dysarthria, and stroke

Abstract

Conference

Fingerprint

Cite this

Application of the Lee Silverman voice treatment (LSVT^®) to individuals with multiple sclerosis, ataxic dysarthria, and stroke